Tatvik Biosystems Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -63.64%
- Profit Growth 50.30%
- Ebitda -72.18%
- Net Worth -969.94%
- Total Assets -40.79%
About Tatvik Biosystems
Tatvik Biosystems Private Limited (TBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 18 May 2016 (Eight years and eight months 23 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anmol Kumar and Priyanka Sharma serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
-
Apps
Corporate Identity Details
-
CIN/LLPIN
U29190DL2016PTC299966
-
Company No.
299966
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 May 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Tatvik Biosystems Private Limited offer?
Tatvik Biosystems Private Limited offers a wide range of products and services, including Biometrics & Access Control Devices, Fingerprint Scanners, Scanner, Passport Reader, Billing Machines, GPS and Navigation Devices, GPS Accessories.
Who are the key members and board of directors at Tatvik Biosystems?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anmol Kumar
|
Director | 18-May-2016 | Current |
|
Priyanka Sharma
|
Director | 01-Apr-2021 | Current |
Financial Performance of Tatvik Biosystems.
Tatvik Biosystems Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 63.64% decrease. The company also saw a substantial improvement in profitability, with a 50.3% increase in profit. The company's net worth observed a substantial decline by a decrease of 969.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tatvik Biosystems?
In 2021, Tatvik Biosystems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tatvik Biosystems?
Unlock and access historical data on people associated with Tatvik Biosystems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tatvik Biosystems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tatvik Biosystems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
